Unknown NA INTERVENTIONAL 2-arm NCT01599078

Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention (PacTAP)

Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention (PacTAP Study): A Double Blind, Randomized Control Study

Sponsor: Midwest Cardiovascular Research Foundation

Conditions Peripheral Arterial Disease Restenosis

Interventions Paclitaxel Placebo

Updated 4 times since 2017 Last updated: May 13, 2012 Started: Jan 31, 2012 Primary completion: Jan 31, 2013 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Peripheral Arterial Disease and Restenosis and is currently ongoing. Midwest Cardiovascular Research Foundation leads this study, which shows 4 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jan 2017 — Jan 2021 [monthly]

Unknown Status NA

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Midwest Cardiovascular Research Foundation
Spectranetics Corporation

Data source: Midwest Cardiovascular Research Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bettendorf, United States